Gut heavy metal and antibiotic resistome of humans living in the high Arctic

Front Microbiol. 2024 Oct 30:15:1493803. doi: 10.3389/fmicb.2024.1493803. eCollection 2024.

Abstract

Contaminants, such as heavy metals (HMs), accumulate in the Arctic environment and the food web. The diet of the Indigenous Peoples of North Greenland includes locally sourced foods that are central to their nutritional, cultural, and societal health but these foods also contain high concentrations of heavy metals. While bacteria play an essential role in the metabolism of xenobiotics, there are limited studies on the impact of heavy metals on the human gut microbiome, and it is so far unknown if and how Arctic environmental contaminants impact the gut microbes of humans living in and off the Arctic environment. Using a multiomics approach including amplicon, metagenome, and metatranscriptome sequencing, we identified and assembled a near-complete (NC) genome of a mercury-resistant bacterial strain from the human gut microbiome, which expressed genes known to reduce mercury toxicity. At the overall ecological level studied through α- and β-diversity, there was no significant effect of heavy metals on the gut microbiota. Through the assembly of a high number of NC metagenome-assembled genomes (MAGs) of human gut microbes, we observed an almost complete overlap between heavy metal-resistant strains and antibiotic-resistant strains in which resistance genes were all located on the same genetic elements.

Keywords: Arctic; antimicrobial resistance; co-resistance; contaminants; heavy metal resistance; mer-operon.

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was supported by the Novo Nordisk Foundation (grant number NNF20OC0061343 awarded to Professor Anders Albrechtsen). Aviaja Lyberth Hauptmann was supported by the Danish Government’s funding for Arctic research (80.23), the Carlsberg Foundation (CF19-0401), and the Aage V. Jensen Charity Foundation (2022). Simon Rasmussen and Joachim Johansen were supported by the Novo Nordisk Foundation (grant number NNF14CC0001).